This Biotech Is Ripping Following Phase 1b Trial Announcement

This Biotech Is Ripping Following Phase 1b Trial Announcement

By: Tomas Ronolski - AllPennyStocks.com News

Wednesday, April 9, 2025

A biotech company based out of Massachusetts is turning heads so far during Wednesday’s session after the company announced its Safety Monitory Committee recommended dose escalation in its Phase 1b trial of PH-762.

Naturally traders rushed to buy up shares of Phio Pharmaceuticals Corp. (Nasdaq:PHIO), pushing the micro cap up to $2.73/share (+170.30%) at the early session high. This move could be an indication of a potential breakout as this stock fights to get out of the year-long downtrend it has been stuck in.

Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others.

Copyright © 2025 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Still Burning Bright: Why Coal Remains a Cornerstone of Global Energy and Industry

Read More

Acquisition Announcement Sparks Buying Spree For This Micro Cap

Read More

Biotech Company Sees Stock Boost Following Major Strategy Shift

Read More

Most Popular

1

Updated Mineral Resource Strengthens Micro Cap’s Development Plans in Chile

2

Biotech Company Sees Stock Boost Following Major Strategy Shift

3

Tech Firm’s Stock Rallies On News of Lucrative Multi-Year Agreement

4

Still Burning Bright: Why Coal Remains a Cornerstone of Global Energy and Industry

5

Alberta eyes oil slump, but retains optimism over U.S. peers

6

Trump’s Tariffs Leave No Safe Harbor for American Importers

AllPennyStocks.com Favorites

1

West Africa's Hidden Gem: A Penny Play with Golden Potential

Enable Free Access to Unlock Up to Two Articles Per Month.

2

This Beaten-Down Biotech Could Be a Major Comeback Story

Enable Free Access to Unlock Up to Two Articles Per Month.

3

TSX-Venture listed, Tier One Silver Inc. looks ready to rally as the stock exhibited a Bullish Moving Average Crossover (20 DMA / 100 DMA). With a closing price of $0.11, we continue to monitor this technical signal for future potential upward movement.

4

Excellon Resources Inc. looks promising from a technical analysis perspective as the OTC Markets listed stock displayed what technicians call a Golden Cross (50 DMA / 200 DMA) on Tuesday. Shares closed at $0.10.

5

TSX-Venture traded, Churchill Resources Inc. took off in Tuesday's trading session. Shares climbed an impressive 100.00%, ending the day at $0.02.

6

OTC Markets traded, Parliament House Enterprises Inc took off in Tuesday's trading session. Shares climbed an impressive 134.38%, ending the day at $0.02.

7

This Junior Miner Is Outperforming At A Shocking Rate

Enable Free Access to Unlock Up to Two Articles Per Month.

8

This Junior Miner Nears Breakout as Gold Surges to New Highs

Enable Free Access to Unlock Up to Two Articles Per Month.

Back to Top

Site Links:

Premium Services / Email Newsletter:

Social Media:

RSS Feed:

Partners:

BullishInvestor.com

© Copyright 2025 AllPennyStocks.com Media Inc. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes.
Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Data is provided by QuoteMedia.com.

© Copyright 1999 – 2025. AllPennyStocks.com Media Inc.
All rights reserved.